Literature DB >> 1852531

The natural history of the appearance of apnea of prematurity.

K Barrington1, N Finer.   

Abstract

Twenty healthy preterm infants of less than 34 wk gestation were studied with continuous recordings, commencing within 8 h of birth, for up to 1 wk of age to determine the usual time course of the appearance of apnea and to classify apnea types. Airway occlusion studies were also performed on a regular basis to determine whether apneic spells were preceded or followed by a reduction in central respiratory drive. Apneic spells of greater than 15 s duration accompanied by hypoxia or bradycardia occurred in all infants before 24 h of age. The frequency of apneic spells was highest in the first 24 h after birth with a mean frequency of 0.9/h and gradually reduced thereafter, falling to 0.2/h by 5 d of age (p less than 0.01). Apneic spells were more likely to be obstructive in the first 2 d of life than thereafter (p less than 0.05). Central apnea was proportionately significantly less frequent during this time period. Reduced respiratory drive, as demonstrated by airway occlusion pressures, was associated with more frequent apnea and was evident at the first occlusion study, which frequently preceded the first significant apnea.

Entities:  

Mesh:

Year:  1991        PMID: 1852531     DOI: 10.1038/pr.1991.72500

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  18 in total

1.  Adaptive mechanical backup ventilation for preterm infants on respiratory assist modes - a pilot study.

Authors:  Susanne Herber-Jonat; Esther Rieger-Fackeldey; Helmut Hummler; Andreas Schulze
Journal:  Intensive Care Med       Date:  2006-01-24       Impact factor: 17.440

2.  Respiratory events in preterm infants prior to discharge: with and without clinically concerning apnoea.

Authors:  Dawn E Elder; Janine Whale; Duncan Galletly; Angela J Campbell
Journal:  Sleep Breath       Date:  2010-12-30       Impact factor: 2.816

3.  Long-term neurological effects of neonatal caffeine treatment in a rabbit model of preterm birth.

Authors:  Lennart Van der Veeken; Susanne Grönlund; Erik Gerdtsson; Bo Holmqvist; Jan Deprest; David Ley; Matteo Bruschettini
Journal:  Pediatr Res       Date:  2019-12-07       Impact factor: 3.756

4.  Very long apnea events in preterm infants.

Authors:  Mary A Mohr; Brooke D Vergales; Hoshik Lee; Matthew T Clark; Douglas E Lake; Anne C Mennen; John Kattwinkel; Robert A Sinkin; J Randall Moorman; Karen D Fairchild; John B Delos
Journal:  J Appl Physiol (1985)       Date:  2014-12-30

5.  Delayed chemoreceptor responses in infants with apnoea.

Authors:  M Katz-Salamon
Journal:  Arch Dis Child       Date:  2004-03       Impact factor: 3.791

6.  A model analysis of arterial oxygen desaturation during apnea in preterm infants.

Authors:  Scott A Sands; Bradley A Edwards; Vanessa J Kelly; Malcolm R Davidson; Malcolm H Wilkinson; Philip J Berger
Journal:  PLoS Comput Biol       Date:  2009-12-04       Impact factor: 4.475

7.  Effect of nursing position on incidence, type, and duration of clinically significant apnoea in preterm infants.

Authors:  L O Kurlak; N R Ruggins; T J Stephenson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-07       Impact factor: 5.747

8.  The effects of caffeine on heart rate variability in newborns with apnea of prematurity.

Authors:  I Ulanovsky; N S Haleluya; S Blazer; A Weissman
Journal:  J Perinatol       Date:  2014-04-10       Impact factor: 2.521

9.  Clinically significant cardiopulmonary events and the effect of definition standardization on apnea of prematurity management.

Authors:  M B F Powell; C R Ahlers-Schmidt; M Engel; B T Bloom
Journal:  J Perinatol       Date:  2016-09-29       Impact factor: 2.521

10.  A Randomized Controlled Trial Comparing Two Doses of Caffeine for Apnoea in Prematurity.

Authors:  Anis Munirah Mohd Kori; Hans Van Rostenberghe; Nor Rosidah Ibrahim; Najib Majdi Yaacob; Ariffin Nasir
Journal:  Int J Environ Res Public Health       Date:  2021-04-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.